Psychedelics and Profit

The conversation delves into the complex dynamics between profit-driven motives and the therapeutic potential of psychedelics. Concerns arise about how market pressures may lead to the commercialization of treatments that prioritize ongoing administration over true healing. Insights highlight the struggles researchers face in securing funding, often caught between philanthropic efforts and the strings attached to corporate sponsorships.